8-K/A: Presto Automation Amends 8-K Filing to Correct Share Issuance Details and Reference Item 3.01

Presto Automation files an amendment to its previous 8-K report to correct share issuance information and include a reference to Item 3.01, following a recent financing round.

Summary

• Presto Automation amended its Form 8-K filing to correct the number of shares issued and issuable after a recent financing round.
• The company entered into Securities Purchase Agreements on January 29, 2024, raising $6 million through subordinated notes and an additional $3 million in exchange for forfeited shares.
• The notes accrue interest at 7.5% per annum, increasing to 12% upon default, and are convertible into common stock at $0.25 per share.
• The notes have full ratchet anti-dilution protection until September 30, 2024, which means the conversion price can be reduced if new shares are issued at a lower price.
• The total number of shares issuable upon conversion of the notes and exercise of warrants is capped at 19.99% of outstanding shares without shareholder approval, which is 14,190,042 shares.
• The company also issued warrants to purchase 5,323,298 shares to the lenders as part of a credit agreement amendment.
• The company is required to hold a shareholder meeting by March 6, 2024, to approve the issuance of shares exceeding the 19.99% cap and to increase the authorized shares of common stock.
• Presto anticipates a breach of its operating cash covenant under the Credit Agreement in February, which is subject to a forbearance agreement.
• The company projects that current cash resources will sustain operations through the end of February and is exploring additional capital raising options.
• The company is required to raise at least $6 million by March 8, 2024, to receive further forbearance from lenders.

Sentiment

Score: 3

Explanation: The document indicates significant financial challenges, including a need for immediate capital and potential covenant breaches, leading to a negative sentiment.

Positives

• The company successfully raised $9 million through a combination of cash investment and share forfeiture.
• The notes have a full ratchet anti-dilution protection, which protects investors from future dilution until September 30, 2024.
• The company secured a forbearance agreement with lenders, providing temporary relief from potential defaults.
• The company is actively exploring additional capital raising options to ensure continued operations.

Negatives

• The company anticipates breaching its operating cash covenant under the Credit Agreement in February.
• The company is required to raise at least $6 million by March 8, 2024, to avoid an event of default.
• The conversion price of the notes can be reduced if new shares are issued at a lower price, potentially diluting existing shareholders.
• The company's liquidity is only projected to last through the end of February without additional funding.

Risks

• The company's ability to secure additional capital resources is uncertain.
• Failure to raise at least $6 million by March 8, 2024, will result in an event of default under the Credit Agreement.
• The company's operating cash is projected to breach the permitted covenant under the Credit Agreement in February.
• The full ratchet anti-dilution protection could lead to significant dilution of existing shareholders if the company issues shares at a lower price.
• The company is dependent on shareholder approval to issue shares exceeding the 19.99% cap.

Future Outlook

The company is exploring alternatives and in discussions with potential investors to raise additional capital. The company projects that current cash resources will sustain operations through the end of February. The company is required to raise at least $6 million on or before March 8, 2024 pursuant to the terms of the Forbearance Agreement in order to receive additional forbearance from the Lenders.

Management Comments

• The company is exploring alternatives and in discussions with potential investors to raise capital.
• The company projects that the net proceeds from the Offering, together with the Company's other cash resources and projected revenues, are sufficient for the Company to sustain its operations through the end of February.

Industry Context

This announcement reflects a company in a challenging financial position, needing to secure additional funding to continue operations. The use of convertible notes with anti-dilution protection is a common strategy for companies seeking capital in difficult circumstances. The need for shareholder approval for additional share issuance highlights the company's reliance on external funding and the potential for further dilution.

Comparison to Industry Standards

• The use of convertible notes with anti-dilution protection is a common practice for companies in Presto's situation, similar to other tech companies seeking bridge financing.
• The 7.5% interest rate on the notes, increasing to 12% upon default, is relatively high, reflecting the risk associated with the investment, which is typical for distressed companies.
• The conversion price of $0.25 per share is significantly below the previous share price of $1.00 and $2.00 in prior offerings, indicating a substantial decrease in valuation.
• The requirement to raise $6 million by March 8, 2024, is a critical deadline, similar to other companies facing liquidity constraints and needing to meet specific funding milestones to avoid default.

Related Party Transactions

• Remus Capital, an entity controlled by the company's Chairman, purchased $2.675 million of the notes.
• CA, affiliated with a director of Presto, received additional shares due to anti-dilution provisions.

Stakeholder Impact

• Shareholders face potential dilution due to the issuance of new shares and the anti-dilution provisions.
• Lenders have extended forbearance but require the company to raise additional capital.
• Employees face uncertainty due to the company's financial challenges.
• Customers and suppliers may be concerned about the company's long-term viability.

Next Steps

• The company needs to hold a shareholder meeting by March 6, 2024, to approve the issuance of shares exceeding the 19.99% cap and to increase the authorized shares of common stock.
• The company needs to raise at least $6 million by March 8, 2024, to receive further forbearance from lenders.
• The company will file a registration statement with the SEC within 30 days for the resale of shares issued in the private placement.

Key Dates

Keywords

capital raise, subordinated notes, convertible notes, anti-dilution, warrants, forbearance, share issuance, credit agreement, liquidity, shareholder approval